share

Axitinib-13C-D3 CAS NO 1261432-00-1


Unit Price:

CAS No.:1261432-00-1

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Axitinib-13C-D3 is a stable isotope-labeled analog of the tyrosine kinase inhibitor Axitinib, specifically designed for use as an internal standard in quantitative bioanalytical studies. This high-purity compound is essential for ensuring the accuracy and reliability of mass spectrometry-based assays, particularly in pharmacokinetic and metabolism research. It is a critical tool for pharmaceutical R&D laboratories, contract research organizations (CROs), and academic institutions focused on oncology drug development and bioanalytical method validation.

Application

  • Quantitative Bioanalysis: Serves as an internal standard in LC-MS/MS and GC-MS methods for the precise quantification of Axitinib in biological matrices (plasma, serum, tissue homogenates).
  • Pharmacokinetic (PK) Studies: Enables accurate tracking of drug absorption, distribution, metabolism, and excretion (ADME) profiles in preclinical and clinical research.
  • Metabolite Identification & Profiling: Aids in the detection and structural elucidation of drug metabolites by providing a stable isotopic reference point.
  • Method Development & Validation: Critical for developing robust, sensitive, and selective analytical methods compliant with FDA, EMA, and ICH guidelines.
  • Drug Metabolism and Pharmacokinetics (DMPK): Used in high-throughput screening and in-vitro studies to understand metabolic stability and enzyme kinetics.
  • Quality Control in Manufacturing: Can be utilized in impurity profiling and stability-indicating assays for the parent drug substance.

Basic Information

Product Name Axitinib-13C-D3
CAS No. 1261432-00-1
Molecular Formula C22H1513C D3N4O
Molecular Weight ~387.43 g/mol
Synonyms Axitinib-(phenyl-13C6,d3); N-Methyl-2-[[3-((E)-2-pyridin-2-yl-ethenyl)-1H-indazol-6-yl]sulfanyl]-benzamide-13C6,d3; AG-013736-13C-D3; Axitinib Isotopically Labeled Standard; Axitinib Internal Standard; [13C6,D3]-Axitinib; Stable Isotope-Labeled Axitinib
EINECS Contact for details

Quality Control

Every batch of Axitinib-13C-D3 is manufactured and analyzed under strict quality management systems. We guarantee high chemical and isotopic purity, supported by comprehensive analytical data including NMR, HPLC, and mass spectrometry. A Certificate of Analysis (COA) detailing purity, isotopic enrichment, and solvent content is provided with each shipment to ensure compliance with your research and regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below in a dry, cool place. This product is hygroscopic (moisture-sensitive). For long-term storage, keep the container under an inert atmosphere. Allow the vial to warm to room temperature in a desiccator before opening to prevent condensation and moisture absorption.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC-MS) Conforms
Purity (HPLC) ≥98.0%
Isotopic Purity ≥99 atom % 13C; ≥98 atom % D
Chemical Purity ≥95%
Water Content (KF) ≤1.0%
Residual Solvents (GC) Complies with ICH Q3C

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.